Krakow, Poland-based Intelliseq has announced a new distribution partnership with DNA ALLY. As Intelliseq’s official partner in the U.S. market, DNA ALLY will help bring the IntelliseqFlow web-based platform for next-generation sequencing (NGS) data analysis to facilities across the country.
DNA ALLY’s genetic counselors helped Intelliseq create user-friendly and accessible DNA test reports dedicated to diagnosticians. The new partnership will enable distribution partners to offer the IntelliseqFlow platform to laboratories and hospitals throughout the U.S. market.
The IntelliseqFlow platform translates raw DNA data into complete reports with clinical insights (from .fastq to .pdf). The available workflows are dedicated to different fields of genome-based medicine, including genetic disorders, pharmacogenomics (PGx), and polygenic risk scores for health- and wellness-related traits.
Featured Image: The Intelliseq platform translates raw DNA data into complete reports with clinical insights. Photo: Intelliseq